Inpatient Opioid Safety Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Nov 9, 2021)
Inpatient Opioid Safety Act of 2021
This bill requires hospitals, as a condition of Medicare and Medicaid participation, to use specified technology to monitor patients for opioid-induced respiratory depression for 12 hours after the administration of an opioid or until the patient is discharged, whichever is earlier, unless a health care practitioner determines before administering an opioid that such monitoring should not be used and records this determination in the patient's record.
What just happenedNov 10, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseNov 9, 2021
- Nov 10, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Nov 9, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Nov 9, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Nov 9, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Nov 9, 2021IntroReferralIntro-H
Introduced in House
- Nov 9, 2021IntroReferral1000
Introduced in House